News

Notice of the forthcoming Retina UK AGM – April 2021

Due to the Covid-19 pandemic our 2019 AGM was postponed with the agreement of the Charity Commission. This year the AGM will be held on Saturday, 17 April at 2.45pm: …

Tell us about your favourite book

Reading is a joy which we know that many of our community enjoy, particularly now; the weather is miserable and we’re not supposed to go out, other than for essentials. …

ProQR makes progress with potential treatment for LCA

Despite the challenges of the pandemic, researchers and pharmaceutical companies are still making progress towards delivering new treatments for inherited sight loss. Biotechnology company ProQR Therapeutics has announced that it …

Useful links during Covid-19 pandemic

Originally published March 2020 The following list of useful links have been compiled by the team at Retina UK to provide information and support for our community. The list is …

Volunteers needed to test new memory stick pilot

We have been told by many members of our community that they no longer have a CD player and that the devices they now use have a USB slot for …

Participants needed for Charles Bonnet syndrome (CBS) survey

Researchers at Moorfields Eye Hospital are conducting a short 5-15 minute survey about how the COVID-19 lockdown has affected people with Charles Bonnet syndrome (CBS). Responses to the survey will …

ProQR clinical trial for Leber’s Congenital Amourosis (LCA) 10

  Biopharmaceutical company ProQR is conducting a Phase 2/3 clinical trial (Illuminate) to measure the safety and effectiveness of RNA therapy, Sepofarsen which aims to treat Leber’s Congenital Amourosis (LCA) …

We are here for you

We are all living in challenging times and this is causing uncertainty and anxiety for many in our community. In March we recorded a significant increase in demand for our …

Ask the expert

Would you like to speak with an expert who cares for lots of patients with inherited sight loss conditions and has a detailed knowledge of the field? Consultant Ophthalmologist Dr …

Positive early findings from ProQR trial of USH2A therapy

Biotechnology company ProQR has announced encouraging results from its early analysis of the phase 1/2 trial of QR-421a, an innovative approach to treating sight loss caused by mutations in a …

Retina UK COVID-19 response

During these uncertain times, the health and wellbeing of our community is our upmost priority at Retina UK. In light of Government guidance we have made the difficult decision to …